NCT02583022View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

August 31, 2015

Conditions
Atopic Dermatitis
Interventions
DRUG

PAC-14028 cream 1.0%

Topical application

DRUG

PAC-14028 cream vehicle

Topical application

DRUG

Elidel cream 1%

Topical application

All Listed Sponsors
lead

Amorepacific Corporation

INDUSTRY

NCT02583022 - A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis | Biotech Hunter | Biotech Hunter